Review
[Yellow fever]
[Article in
Polish]
Affiliations
- PMID: 15807166
Item in Clipboard
Review
[Yellow fever]
[Article in
Polish]
Przegl Epidemiol.
2004.
Abstract
Yellow fever is a mosquito born viral illness that causes hemorrhagic fever in tropical Africa and South America. An estimated 200 000 people are still infected annually. There is no antiviral therapy available and vaccination is major strategy in the control yellow fever. From 60 years ago is available very safe and efficient vaccine. The vaccine is a live attenuated virus strain 17D. Recently identified vaccine associated viscerotropic diseases (YFV-AVD). This paper describes knowledge about yellow fever disease, vaccine associated adverse events and actually recommendation for vaccine use.
Similar articles
-
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.Vaccine. 2004 Jun 2;22(17-18):2103-5. doi: 10.1016/j.vaccine.2004.01.026. Vaccine. 2004. PMID: 15149765
-
Yellow fever-associated viscerotropic disease in Barcelona, Spain.J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x. J Travel Med. 2008. PMID: 18494699 Review.
-
Review of the risks and benefits of yellow fever vaccination including some new analyses.Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Expert Rev Vaccines. 2012. PMID: 22551029 Review.
-
Yellow fever vaccine-associated viscerotropic disease and death in Spain.J Clin Virol. 2006 Jun;36(2):156-8. doi: 10.1016/j.jcv.2006.02.005. Epub 2006 Apr 4. J Clin Virol. 2006. PMID: 16597510
-
Viscerotropic disease following yellow fever vaccination in Peru.Vaccine. 2009 Oct 9;27(43):5974-81. doi: 10.1016/j.vaccine.2009.07.082. Epub 2009 Aug 11. Vaccine. 2009. PMID: 19679215